Abstract:Abstract Background Frontotemporal lobar degeneration (FTLD) represents a clinically, pathologically and genetically heterogenous neurodegenerative disorder, often complicated by neurological signs such as motor neuron-related limb weakness, spasticity and paralysis, parkinsonism and gait disturbances. Linkage to chromosome 9p had been reported for pedigrees with the neurodegenerative disorder, frontotemporal lobar degeneration (FTLD) and motor neuron disease (MND). The objective in this study is to identify the genetic locus in a multi-generational Australian family with FTLD-MND. Methods Clinical review and standard neuropathological analysis of brain sections from affected pedigree members. Genome-wide scan using microsatellite markers and single nucleotide polymorphism fine mapping. Examination of candidate genes by direct DNA sequencing. Results Neuropathological examination revealed cytoplasmic deposition of the TDP-43 protein in three affected individuals. Moreover, we identify a family member with clinical Alzheimer's disease, and FTLD-Ubiquitin neuropathology. Genetic linkage and haplotype analyses, defined a critical region between markers D9S169 and D9S1845 on chromosome 9p21. Screening of all candidate genes within this region did not reveal any novel genetic alterations that co-segregate with disease haplotype, suggesting that one individual carrying a meiotic recombination may represent a phenocopy. Re-analysis of linkage data using the new affection status revealed a maximal two-point LOD score of 3.24 and a multipoint LOD score of 3.41 at marker D9S1817. This provides the highest reported LOD scores from a single FTLD-MND pedigree. Conclusion Our reported increase in the minimal disease region should inform other researchers that the chromosome 9 locus may be more telomeric than predicted by published recombination boundaries. Moreover, the existence of a family member with clinical Alzheimer's disease, and who shares the disease haplotype, highlights the possibility that late-onset AD patients in the other linked pedigrees may be mis-classified as sporadic dementia cases.

A pathogenic progranulin mutation and C9orf72 repeat expansion in a family with frontotemporal dementia

A novel GRN mutation (GRN c.708+6_+9delTGAG) in frontotemporal lobar degeneration with TDP-43-positive inclusions: clinicopathologic report of 6 cases

Pathogenic cysteine mutations affect progranulin function and production of mature granulins.

A case of familial frontotemporal dementia caused by a progranulin gene mutation

From genotype to phenotype: two cases of genetic frontotemporal lobar degeneration with premorbid bipolar disorder

Two novel variants in GRN: the relevance of CNV analysis and genetic screening in FTLD patients with a negative family history

An Alternative In Vitro Model Of Neurodegeneration In Ftld-U With Pgrn Mutation

Transcriptomic and Network Meta-Analysis of Frontotemporal Dementias

Unveiling New Genetic Variants Associated with Age at Onset in Alzheimer's Disease and Frontotemporal Lobar Degeneration Due to C9orf72 Repeat Expansions

The clinical and pathological phenotypes of frontotemporal dementia with C9ORF72 mutations.

Pedigree with frontotemporal lobar degeneration – motor neuron disease and Tar DNA binding protein-43 positive neuropathology: genetic linkage to chromosome 9

Clinico-genetic findings in 509 frontotemporal dementia patients

Clinical, neuropathological, and genetic characteristics of the novel IVS9+1delG GRN mutation in a patient with frontotemporal dementia

Alzheimer neuropathology without frontotemporal lobar degeneration hallmarks (TAR DNA-binding protein 43 inclusions) in missense progranulin mutation Cys139Arg

Frontotemporal Dementia-Related Gene Mutations in Clinical Dementia Patients from a Chinese Population

Ftd-Psp Is An Unusual Clinical Phenotype In A Frontotemporal Dementia Patient With A Novel Progranulin Mutation

GRN deletion in familial frontotemporal dementia showing association with clinical variability in 3 familial cases

Distinct Neurological Disorders with C9orf72 Mutations: Genetics, Pathogenesis, and Therapy.

Deciphering Distinct Genetic Risk Factors for FTLD-TDP Pathological Subtypes via Whole-Genome Sequencing

Intrafamilial clinical phenotypic heterogeneity with progranulin gene p.Glu498fs mutation

C9ORF72 hexanucleotide repeat expansion: From ALS and FTD to a broader pathogenic role?